| CAS ID: | 99489-94-8 |
| Molecular Formula: | |
| Molecular Weight: | g/mol |
| Monoisotopic Mass: | g/mol |
| Class: | Peptide |
| Natural Product: | No |
| Other Names: | SERELAXIN | RLX030 |
| Analysis: | N/A |
Reference Record 1
| PubMed ID | 27647937 | Target ID | |
| Uniprot ID | Name | ||
| Model | vitro,mice | Fibrosis Disease | Airway fibrosis |
| Process I | attenue inflammation | ||
| Process II | myofibroblast activation,cells proliferation | ||
| Process III | prevenet collagen deposition | ||
| Mechanism | |||
Trial Record 1
| ClinicalTrial ID | NCT02669875 | Disease | Liver fibrosis |
| Phase | Phase 2 | Status | Completed |
| First Received | February 1, 2016 | Last Verified | October 11, 2018 |
| Sponsor | University of Edinburgh | ||
Trial Record 2
| ClinicalTrial ID | NCT01640964 | Disease | Liver fibrosis |
| Phase | Phase 2 | Status | Completed |
| First Received | July 16, 2012 | Last Verified | March 15, 2016 |
| Sponsor | Novartis Pharmaceuticals | ||
| PubChem: | 71300755 |
| ChEMBL: | CHEMBL2108358 |